The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

The Trump administration’s first drug pricing action — rescinding a Biden executive order encouraging Medicare to help lower prescription costs — is befuddling drug pricing experts.

Trump has so far not targeted any of Biden's signature healthcare policies, including Medicare drug pricing negotiation powers, the $35 monthly cap on insulin copays, and the $2,000 annual cap on out-of-pocket spending on prescription drug costs.

On Day 1 of his second term of office, Trump rescinded Biden's Executive Order 14087, "Lowering Prescription Drug Costs for Americans." Trump's action ha

First-day administration moves also helped short-term health insurance and ended several Medicare efforts to change the way the drug market works.

President Trump is rolling back Biden healthcare policies, such as expansions to the Affordable Care Act – a move Democrats described as an "attack" on the federal program.

As President Donald Trump’s health care agenda for a second term takes shape, it’s becoming clear that many Biden-era policies won’t make the cut.